Home| Journals | About Us|Contact Us|www.statperson.com

 
Untitled Document

[Abstract] [PDF] [HTML] [Linked References]

MedPulse - International Medical Journal, ISSN 2348-2516 E-ISSN: 2348-1897

Volume 1, Issue 6, June 2014 pp 310-315

Research Article

Efficacy of isotretinoin alone and its combination with azithromycin in moderate to severe acne vulgaris: a comparative study

Kishor Singh1, Amarjeet Singh2, Sanjay Kanodia3, Jyoti Singh4, Akansha Trehan5

1Professor and HOD, 2Resident, 3Associate Professor, 5Resident, Department of Dermatology, Venereology and Leprosy, National Institute of Medical Sciences, Jaipur, Rajasthan, INDIA.

4Resident, Department of Pathology, Lala Laajpat Rai Medical College, Meerut, Uttar Pradesh, INDIA.

Linked References

  1. Bellosta M, Vignini M, Miori L, et al. “Low-dose isotretinoin in severe acne”. Int JTissue React 1987;9:443-6.
  2. Plewig G, Dressel H, Pfleger M, et al.“Low dose isotretino in combined with tretinoin is effective to correct abnormalities of acne”. J Dtsch Dermatol Ges 2004; 2:31-45.
  3. Strauss JS, Leyden JJ, Lucky AW, et al.“A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne”. J Am Acad Dermatol 2001; 45:187-95.
  4. Akman A,Durusoy C,Senturk M, et al.“Treatment of acne with intermittent and conventional isotretinoin : A randomized, controlled multicenter study”. Arch Dermatol Res 2007; 299:467-73.
  5. Fernandez-Obregon AC. Azithromycin for the treatment of acne. Int J Dermatol. 1997; 36: 239-40.
  6. Fernandez-Obregon AC. Azithromycin for the treatment of acne. Int J Dermatol. 2000; 39:45-50.
  7. Kus S, Yucelten D, Aytug A. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. Clin Exp Dermatol. 2005; 30:215-20.
  8. Gollnick H, Cunliffe W, Berson D et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003; 49(Suppl 1):S1-37.
  9. Tan AW, Tan HH. Acne vulgaris: a review of antibiotic therapy. Expert Opin Pharmacother. 2005 Mar; 6(3):409-18.
  10. Bloch, B: Metabolism, endocrine glands and skin disease with special reference to acne vulgaris and xanthoma. Br. J. Derm symph. 1931; 43: 61-870.
  11. Sulzberger, MB and Witten, VH: Hormone and acne vulgaris. Med. Clin N Amer. 1951; 35: 373-390.
  12. Leider M and Rosenblum M: A Dictionary of Dermatological words, terms and phrases, New York. Mc Graw Hill, 1968.
  13. Hardy DJ, Henesey DM, Beyer JM et al. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother. 1988; 32:1710-19.
  14. Neu HC. Clinical microbiology of azithromycin. Am J Med. 1991; 91(Suppl. 3A):12S-18S.
  15. Duran JM, Amsden GW. Azithromycin: indications for the future? Expert Opin Pharmacother. 2000 Mar; 1(3):489-505.
  16. Kapadia N, Talib A. Acne treated successfully with azithromycin. Int J Dermatol. 2004 Oct; 43(10):766-7.
  17. Caputo R, Barbareschi M, Veraldi S. Azithromycin: a new drug for systemic treatment of inflammatory acneic lesions. G Ital Dermatol Venereol. 2003; 138:327-31.
  18. Scheinfeld NS, Tutrone WD, Torres O, Weinberg JM. Macrolides in dermatology. Clin Derm. 2003; 21:40-9.
  19. Alvarez-Elroco S, Enzler MJ. The macrolides, erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc. 1999; 74:613-34.
  20. Ross JI, Snelling AM, Carnegie E et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003; 148:467-78.
  21. Rafiei R, Yaghoobi R. Azithromycin versus tetracycline in the treatment of acne vulgaris. J Dermatolog Treat. 2006; 17(4):217-21.



     

 
 
 
 
 
 
     
  Copyrights statperson consultancy www

Copyrights © MedPulse Publishing Corporation www.medpulse.in  2017. All Rights Reserved.